The snacks are now part of a Class I recall, which is for products with the potential of "serious adverse health consequences ...
The number of hospitalizations and deaths from foodborne illness doubled last year compared to 2023 in the U.S.
On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...
A clinical trial comparing a one-page medication handout proposed by the U.S. Food and Drug Administration (FDA) with an ...
EssilorLuxottica's Nuance Audio Glasses receive FDA clearance for OTC sales in the US, revolutionizing hearing solutions with ...
Following a recall of grounding pads produced by Megadyne, a machinery industry company, the FDA is notifying veterinarians ...
A device long used by adults to manage migraines was now available for children as young as eight years old, offering new ...
Jacek Olczak, Philip Morris International CEO, joins CNBC's 'Money Movers' to discuss the company's most recent earnings.